EhP3, a homolog of 14-3-3 family of protein participates in actin reorganization and phagocytosis in Entamoeba histolytica

被引:15
|
作者
Agarwal, Shalini [1 ]
Anand, Gaurav [2 ]
Sharma, Shalini [1 ]
Rath, Pragyan Parimita [1 ]
Gourinath, Samudrala [1 ]
Bhattacharya, Alok [1 ,3 ]
机构
[1] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India
[2] Int Ctr Genet Engn & Biotechnol, New Delhi, India
[3] Ashoka Univ, PO Rai, Sonepat, Haryana, India
关键词
CYTOSKELETON; EXPRESSION; 14-3-3-PROTEINS; PROLIFERATION; ADF/COFILIN; REGULATORS; INSIGHTS;
D O I
10.1371/journal.ppat.1007789
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The highly conserved proteins of the 14-3-3 family are universal adaptors known to regulate an enormous range of cellular processes in eukaryotes. However, their biological functions remain largely uncharacterized in pathogenic protists comprising of several 14-3-3 protein isoforms. In this study, we report the role of 14-3-3 in coordinating cytoskeletal dynamics during phagocytosis in a professional phagocytic protist Entamoeba histolytica, the etiological agent of human amebiasis. There are three isoforms of 14-3-3 protein in amoeba and here we have investigated Eh14-3-3 Protein 3 (EhP3). Live and fixed cell imaging studies revealed the presence of this protein throughout the parasite phagocytosis process, with high rate of accumulation at the phagocytic cups and closed phagosomes. Conditional suppression of EhP3 expression caused significant defects in phagocytosis accompanied by extensive diminution of F-actin at the site of cup formation. Downregulated cells also exhibited defective recruitment of an F-actin stabilizing protein, EhCoactosin at the phagocytic cups. In addition, mass spectrometry based analysis further revealed a large group of EhP3-associated proteins, many of these proteins are known to regulate cytoskeletal architecture in E histolytica. The dynamics of these proteins may also be controlled by EhP3. Taken together, our findings strongly suggest that EhP3 is a novel and a key regulatory element of actin dynamics and phagocytosis in E. histolytica.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] The 14-3-3 Protein Family and Schizophrenia
    Navarrete, Meaghan
    Zhou, Yi
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [2] Molecular evolution of the 14-3-3 protein family
    Wang, WF
    Shakes, DC
    JOURNAL OF MOLECULAR EVOLUTION, 1996, 43 (04) : 384 - 398
  • [3] 14-3-3β targets the actin bundling protein myopodin to the nucleus
    Faul, C
    Schwarz, K
    Heider, T
    Mundel, P
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 525A - 525A
  • [4] DNA binding properties of 14-3-3 protein family
    Cechova, J.
    Coufal, J.
    Jagelska, E. B.
    Brazda, V.
    FEBS JOURNAL, 2012, 279 : 463 - 463
  • [5] The Calmodulin-like Calcium Binding Protein EhCaBP3 of Entamoeba histolytica Regulates Phagocytosis and Is Involved in Actin Dynamics
    Aslam, Saima
    Bhattacharya, Sudha
    Bhattacharya, Alok
    PLOS PATHOGENS, 2012, 8 (12)
  • [6] Human cruciform binding protein belongs to the 14-3-3 family
    Todd, A
    Cossons, N
    Aitken, A
    Price, GB
    Zannis-Hadjopoulos, M
    BIOCHEMISTRY, 1998, 37 (40) : 14317 - 14325
  • [7] Structural basis for protein-protein interactions in the 14-3-3 protein family
    Yang, Xiaowen
    Lee, Wen Hwa
    Sobott, Frank
    Papagrigoriou, Evangelos
    Robinson, Carol V.
    Grossmann, J. Gunter
    Sundstroem, Michael
    Doyle, Declan A.
    Elkins, Jonathan M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (46) : 17237 - 17242
  • [8] Crystallization of a 14-3-3 protein
    Xiao, B
    Jones, D
    Madrazo, J
    Soneji, Y
    Aitken, A
    Gamblin, S
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1996, 52 : 203 - 206
  • [9] A PLANT HOMOLOG TO MAMMALIAN BRAIN 14-3-3 PROTEIN AND PROTEIN-KINASE-C INHIBITOR
    HIRSCH, S
    AITKEN, A
    BERTSCH, U
    SOLL, J
    FEBS LETTERS, 1992, 296 (02) : 222 - 224
  • [10] DYSREGULATED 14-3-3 FAMILY IN SCHIZOPHRENIA
    Qing, Ying
    Wan, Chunling
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S333 - S333